Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter

Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):835-838. doi: 10.1007/s13318-015-0298-x.

Abstract

Background and objectives: Ureteral motility is essential for elimination of intraluminal stones, and it may be adversely affected by cardiovascular drugs that a patient is taking chronically. The aim of our study was to test whether ACE inhibitors and an angiotensin receptor blocker may influence spontaneous contractions of isolated human ureter.

Methods: Both phasic and tonic contractions of the isolated ureteral segments taken from 10 patients were measured as changes of the longitudinal tension or pressure recordings. Captopril, enalapril and losartan were separately added to the organ baths cumulatively.

Results: While enalapril (2.7 × 10-7-3.9 × 10-4 M) and captopril (6.1 × 10-7-2.7 × 10-3 M) did not affect either spontaneous activity or tone of isolated ureteral segments, losartan (2.9 × 10-7-4.2 × 10-4 M) caused concentration-dependent inhibition of spontaneous contractions of the segments (50 % effective concentration (EC50) = 13.46 ± 1.80 × 10-6 M; F = 10.72, r = 0.79, p < 0.001).

Conclusions: Due to differences in molecular mechanism of action, angiotensin receptor blocker losartan does and ACE inhibitors captopril and enalapril do not inhibit spontaneous contractions of isolated human ureter.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Angiotensin II Type 1 Receptor Blockers / pharmacology*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Antihypertensive Agents / pharmacology*
  • Captopril / pharmacology
  • Carcinoma, Renal Cell / physiopathology
  • Carcinoma, Renal Cell / surgery
  • Enalapril / pharmacology
  • Female
  • Humans
  • In Vitro Techniques
  • Losartan / pharmacology*
  • Male
  • Middle Aged
  • Muscle Contraction / drug effects
  • Osmolar Concentration
  • Ureter / drug effects*
  • Ureter / physiopathology

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Enalapril
  • Captopril
  • Losartan